Developer docs
API playgroundTry for free, no card

Search company profiles

Baze

Full company profile

uuid0002l2x

Namestring
Baze
Websiteurl
baze.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Baze was a direct-to-consumer personalized nutrition company that operated an at-home blood testing service, the results of which were used to recommend customized supplements and personalized food plans targeting individual nutrient deficiencies. Its core product surface consisted of three tightly coupled offerings: the Baze At-Home Blood Test (a self-administered kit measuring nutrient biomarkers), Baze Customized Supplements (formulations recommended from the blood test), and Baze Personalized Food Plans (dietary recommendations complementary to the supplement regimen). Underpinning the recommendation engine was an AI-driven personalization layer that translated individual biomarker data into specific supplement and dietary guidance, rather than generic multivitamin recommendations.

The business model combined a one-time revenue stream from blood test kit sales with a recurring subscription revenue stream from personalized supplement replenishment. Go-to-market was direct-to-consumer via Baze's own e-commerce storefront, with marketing emphasizing AI-driven personalization and science-led positioning. Primary customer segments were health-conscious consumers and preventive health seekers - individuals seeking data-driven, customized nutrition rather than mass-market supplements. The company was headquartered in Berlin, Germany, operated with 11-50 employees, and was led by CEO Philipp Schulte alongside co-founders Crina Okumus and Isam Haddad (CTO).

In April 2026, Baze was acquired by Nature's Way (founded 1969, Green Bay, Wisconsin), a strategic acquisition intended to expand Nature's Way's portfolio into personalized health products and AI-driven nutrition solutions. The acquisition positioned Baze's biomarker-driven personalization capability within Nature's Way's broader vitamins, herbs, probiotics, and immune supplement portfolio, including Subscribe & Save and bundle mechanics. Baze operates as a wholly owned subsidiary under the Nature's Way Brands, LLC parent.

Short descriptiontext

Baze is a direct-to-consumer personalized nutrition company that uses at-home blood tests and AI-driven recommendations to deliver customized supplements and food plans to health-conscious consumers. It was acquired by Nature's Way in April 2026.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
personalized nutrition supplements, at-home blood testing, nutrient deficiency analysis, custom supplement formulation, direct-to-consumer wellness
Industry1 code
PRIMARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code1 code
  • Food (Health) Supplement Retailers456191
Product category
Personalized Nutrition
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Blood Test Kits
TypeOne Time License
Description

Direct-to-consumer blood testing kits for nutrient analysis with customized supplement recommendations

nutritionaloutlook.com
2Personalized Supplements
TypeSubscription Recurring
Description

Sale of customized supplements based on individual blood test results and food plan recommendations

nutritionaloutlook.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Marketing or Sales, Technology or R&D, Personnel, Operations
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Baze provides at-home blood test kits that measure nutrient levels and biomarkers to identify individual deficiencies, then delivers customized supplement formulations and personalized food plans tailored to each customer's biochemistry. The blood test results feed into an AI-driven recommendation system that generates specific supplement blends and dietary guidance designed to address identified nutrient gaps.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Helps reduce nutrient deficiencies
Product overview1 text field

Baze is a personalized nutrition company offering a unified at-home blood testing and supplement recommendation service. The core offering consists of an at-home blood test kit that measures biomarkers and nutrient levels, which then informs customized supplement formulations and personalized food plans tailored to individual health requirements. Baze was acquired by Nature's Way in April 2025 as part of its expansion into personalized health products.

Product and service3 records
1Baze At-Home Blood Test
CategoryCore Product
Description

An at-home blood testing kit that measures nutrient levels and biomarkers to identify deficiencies and inform personalized nutrition recommendations for individual consumers.

2Baze Customized Supplements
CategoryCore Product
Description

Personalized supplement formulations tailored to individual blood test results, delivered on a recurring subscription basis to address identified nutrient deficiencies in individual consumers.

3Baze Personalized Food Plans
CategoryCore Product
Description

Customized dietary recommendations designed to complement supplement intake and improve overall nutrient balance, provided to individual consumers based on their blood test data.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-12
Description

Nature's Way acquired Baze in April 2026 as part of its expansion into personalized health products. The acquisition aims to enhance Nature's Way's leadership in quality and innovation in the health and wellness sector. Baze's at-home blood tests and personalized nutrition offerings complement Nature's Way's existing product portfolio.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct peer offering at-home microbiome and blood-based tests that feed AI-generated personalized nutrition and supplement recommendations to consumers. Closely matches Baze's test-plus-supplement subscription model.

TypeDirect peer
Description

Direct peer providing personalized nutrition and wellness plans based on biomarker blood testing. Competes head-to-head with Baze in the data-driven supplement recommendation space.

TypeDirect peer
Description

Direct peer running at-home gut and blood tests paired with AI-driven personalized nutrition scores and food plans. Targets the same health-conscious, prevention-oriented consumer as Baze.

TypeDirect peer
Description

Direct peer that uses at-home microbiome testing to generate personalized nutrition recommendations and food scores. Overlaps with Baze's blood-test-based personalization approach.

5Care/of
TypeDirect peer
Description

Direct peer offering personalized vitamin and supplement packs via a quiz-driven recommendation engine. Competes on the supplement side of Baze's offering, though with less biomarker-driven inputs.

TypeBroad incumbent
Description

Established premium supplement brand that has expanded into at-home health testing and personalized wellness. A broader incumbent competing with Baze across both supplements and testing.

TypeDirect peer
Description

Direct peer in the at-home consumer health testing market, offering a broad menu of blood and biomarker tests. Overlaps with Baze on the at-home testing layer though Baze pairs testing with a custom supplement fulfillment stack.

TypeBroad incumbent
Description

Consumer genetic and health testing platform that provides personalized health and wellness reports. A broader incumbent in personalized consumer health insights rather than blood-nutrient testing specifically.

TypeDirect peer
Description

Direct peer offering personalized vitamin packs based on an intake assessment and optional blood testing. Competes directly with Baze's customized supplement subscription.

TypeEmerging player
Description

Personalized nutrition company using at-home blood tests to generate tailored food and supplement recommendations. Closely mirrors Baze's test-plus-personalized-stack model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Baze

Personalized Nutritionbaze.com

Baze is a direct-to-consumer personalized nutrition company that uses at-home blood tests and AI-driven recommendations to deliver customized supplements and food plans to health-conscious consumers. It was acquired by Nature's Way in April 2026.

What Baze does

Baze was a direct-to-consumer personalized nutrition company that operated an at-home blood testing service, the results of which were used to recommend customized supplements and personalized food plans targeting individual nutrient deficiencies. Its core product surface consisted of three tightly coupled offerings: the Baze At-Home Blood Test (a self-administered kit measuring nutrient biomarkers), Baze Customized Supplements (formulations recommended from the blood test), and Baze Personalized Food Plans (dietary recommendations complementary to the supplement regimen). Underpinning the recommendation engine was an AI-driven personalization layer that translated individual biomarker data into specific supplement and dietary guidance, rather than generic multivitamin recommendations.

The business model combined a one-time revenue stream from blood test kit sales with a recurring subscription revenue stream from personalized supplement replenishment. Go-to-market was direct-to-consumer via Baze's own e-commerce storefront, with marketing emphasizing AI-driven personalization and science-led positioning. Primary customer segments were health-conscious consumers and preventive health seekers - individuals seeking data-driven, customized nutrition rather than mass-market supplements. The company was headquartered in Berlin, Germany, operated with 11-50 employees, and was led by CEO Philipp Schulte alongside co-founders Crina Okumus and Isam Haddad (CTO).

In April 2026, Baze was acquired by Nature's Way (founded 1969, Green Bay, Wisconsin), a strategic acquisition intended to expand Nature's Way's portfolio into personalized health products and AI-driven nutrition solutions. The acquisition positioned Baze's biomarker-driven personalization capability within Nature's Way's broader vitamins, herbs, probiotics, and immune supplement portfolio, including Subscribe & Save and bundle mechanics. Baze operates as a wholly owned subsidiary under the Nature's Way Brands, LLC parent.

Baze firmographics

Firmographics
Name
Baze
Website
https://baze.com
Company type
Private
Founded year
2014
Operating status
Acquired
Headcount range
11–50 employees
Short description
Baze is a direct-to-consumer personalized nutrition company that uses at-home blood tests and AI-driven recommendations to deliver customized supplements and food plans to health-conscious consumers. It was acquired by Nature's Way in April 2026.
Ownership category
akta.pro rank

Baze industry classification

Industry
Product category
Personalized Nutrition
NAICS
Food (Health) Supplement Retailers (456191)
akta.pro industry
PRIMARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • Personalized nutrition supplements
  • At-home blood testing
  • Nutrient deficiency analysis
  • Custom supplement formulation
  • Direct-to-consumer wellness

Where Baze is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Markets served

Baze business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Supply Chain, Marketing or Sales, Technology or R&D, Personnel, Operations

Revenue model

  1. Blood Test Kits: Direct-to-consumer blood testing kits for nutrient analysis with customized supplement recommendations
  2. Personalized Supplements: Sale of customized supplements based on individual blood test results and food plan recommendations

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Baze product offering

Product offering

Core offering

Baze provides at-home blood test kits that measure nutrient levels and biomarkers to identify individual deficiencies, then delivers customized supplement formulations and personalized food plans tailored to each customer's biochemistry. The blood test results feed into an AI-driven recommendation system that generates specific supplement blends and dietary guidance designed to address identified nutrient gaps.

Product overview

Baze is a personalized nutrition company offering a unified at-home blood testing and supplement recommendation service. The core offering consists of an at-home blood test kit that measures biomarkers and nutrient levels, which then informs customized supplement formulations and personalized food plans tailored to individual health requirements. Baze was acquired by Nature's Way in April 2025 as part of its expansion into personalized health products.

Differentiator

Problem solved

Functional benefit

Products and services

  • Baze At-Home Blood Test An at-home blood testing kit that measures nutrient levels and biomarkers to identify deficiencies and inform personalized nutrition recommendations for individual consumers.
  • Baze Customized Supplements Personalized supplement formulations tailored to individual blood test results, delivered on a recurring subscription basis to address identified nutrient deficiencies in individual consumers.
  • Baze Personalized Food Plans Customized dietary recommendations designed to complement supplement intake and improve overall nutrient balance, provided to individual consumers based on their blood test data.

Quantifiable outcome

  • Helps reduce nutrient deficiencies

Companies that use Baze

Customer profile

Segments2 records

Ideal customer profiles2 records

Baze technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature2 records

Baze partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Nature's WaycoreStrategic or Co-development Partner · 12 April 2026Nature's Way acquired Baze in April 2026 as part of its expansion into personalized health products. The acquisition aims to enhance Nature's Way's leadership in quality and innovation in the health and wellness sector. Baze's at-home blood tests and personalized nutrition offerings complement Nature's Way's existing product portfolio.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Baze competitors and assessment

Company assessment

Direct peers

  • Viome Life Sciences: Direct peer offering at-home microbiome and blood-based tests that feed AI-generated personalized nutrition and supplement recommendations to consumers. Closely matches Baze's test-plus-supplement subscription model.
  • InsideTracker: Direct peer providing personalized nutrition and wellness plans based on biomarker blood testing. Competes head-to-head with Baze in the data-driven supplement recommendation space.
  • ZOE: Direct peer running at-home gut and blood tests paired with AI-driven personalized nutrition scores and food plans. Targets the same health-conscious, prevention-oriented consumer as Baze.
  • DayTwo: Direct peer that uses at-home microbiome testing to generate personalized nutrition recommendations and food scores. Overlaps with Baze's blood-test-based personalization approach.
  • Care/of: Direct peer offering personalized vitamin and supplement packs via a quiz-driven recommendation engine. Competes on the supplement side of Baze's offering, though with less biomarker-driven inputs.
  • Everlywell: Direct peer in the at-home consumer health testing market, offering a broad menu of blood and biomarker tests. Overlaps with Baze on the at-home testing layer though Baze pairs testing with a custom supplement fulfillment stack.
  • Persona Nutrition: Direct peer offering personalized vitamin packs based on an intake assessment and optional blood testing. Competes directly with Baze's customized supplement subscription.

Broad incumbents

  • Thorne: Established premium supplement brand that has expanded into at-home health testing and personalized wellness. A broader incumbent competing with Baze across both supplements and testing.
  • 23andMe: Consumer genetic and health testing platform that provides personalized health and wellness reports. A broader incumbent in personalized consumer health insights rather than blood-nutrient testing specifically.

Emerging players

  • Habit (Campbell Soup): Personalized nutrition company using at-home blood tests to generate tailored food and supplement recommendations. Closely mirrors Baze's test-plus-personalized-stack model.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights7 records

Customer concentration

Baze social profiles

Digital presence

Baze financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Baze leadership team

Management profile

Number of profiles

Profiles3 records

Baze funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Baze M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Baze

What does Baze do?

Baze provides at-home blood test kits that measure nutrient levels and biomarkers to identify individual deficiencies, then delivers customized supplement formulations and personalized food plans tailored to each customer's biochemistry. The blood test results feed into an AI-driven recommendation system that generates specific supplement blends and dietary guidance designed to address identified nutrient gaps.

Is Baze a public or private company?

Baze is a private company. It is classified as corporate owned and is currently acquired.

When was Baze founded?

Baze was founded in 2014. It employs 11 to 50 people.

Where is Baze based?

Baze is headquartered in Cambridge, United States, in the North America region.

How does Baze make money?

Two revenue lines are on record. Blood Test Kits are the primary driver. The others are personalized Supplements.

Who are Baze's main competitors?

Direct peers on record are Viome Life Sciences, InsideTracker, ZOE, DayTwo, Care/of, Everlywell and Persona Nutrition. Broad incumbents are Thorne and 23andMe. Habit (Campbell Soup) is listed as an emerging player.

Does Baze have an API?

No public API is recorded for Baze.

What industry is Baze in?

Baze's product category is Personalized Nutrition. Its primary akta.pro industry code is HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 456191.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Nutritional OutlookNature’s Way acquires Baze, expanding its portfolio to personalized nutritionNature's Way (Boston, MA) has acquired Baze (Green Bay, WI), a company offering personalized nutrition through at-home blood tests that measure micronutrient levels. Baze provides custom supplement and food recommendations, claiming to eliminate 73% of customers' nutrient deficiencies within three months. The CEOs of both companies cited the acquisition as a strategic opportunity to expand in the personalized nutrition market, combining Nature's Way's product quality with Baze's personalization capabilities.PR NewswirePersonalized nutrition company Baze announces patent grant on their "feedback loop approach" to micronutrient precisionBaze, a Boston-based personalized nutrition startup, announced it has been awarded a European patent (EP3469359A1) for its 'feedback loop approach' to assessing, recommending, and dosing personalized nutrients. The patented recommendation engine uses customer inputs including blood nutrient levels from at-home testing, anthropometric data, lifestyle information, and health goals to generate precise nutrient recommendations, with the ability to continuously reassess and improve over time. The company, founded in 2014, is expanding its micronutrient biomarkers and exploring integration of digital markers and DNA into its platform.PR NewswireBaze's 'Food Guide' Wins 2020 NutraIngredients-USA Award for 'Personalized Nutrition Initiative of the Year'Personalized nutrition startup Baze was selected by the 2020 NutraIngredients-USA Awards for 'Personalized Nutrition Initiative of the Year' for its Food Guide offering. The Baze Food Guide provides foods and ready-to-eat meals meeting nutritional criteria set by the company's registered dietitians, developed in partnership with Performance Kitchen. The award recognizes Baze's approach of integrating personalized food recommendations alongside its at-home blood testing kit and subscription supplements for micronutrient deficiencies.PR NewswireGlobal Personalized Nutrition Industry Report, 2020 Featuring Profiles of Amway, Balchem, BASF, Baze, Biogeniq, and MoreResearch and Markets has added the "Global Personalized Nutrition Market Analysis & Trends - Industry Forecast to 2028" report to its offerings. The report forecasts strong market growth from 2018 to 2028, driven by evolving lifestyles, rising lifestyle diseases, and increasing disposable income in developing nations. It provides detailed analysis of key players including Amway, Balchem, BASF, Baze, and Biogeniq across various global regions.PR NewswireBoston-Based Personalized Nutrition Startup, Baze, Announces FDA Approval For Blood-Based Testing KitsBaze, a Boston-based personalized nutrition startup, announced FDA approval for its at-home blood collection kit that allows consumers to assess their blood nutrient status. The regulatory milestone enables the company to offer personalized nutrition plans and supplement subscriptions based on individual nutrient analysis through its proprietary Nutrition Information System. The company developed its science-driven approach in Berlin over five years before launching in the United States in 2018.FinSMEsBaze Raises $6M in Series A FundingBaze, a blood-based at-home nutritional testing kit company, closed a $6M Series A round led by Nature's Way. The funds will expand marketing and product offerings, with monthly supplements starting at $15 and a Starter Kit at $99.